Skip to main content

Table 3 Obstacles to repository corticotropin injection access in patients encountering one or more obstacles

From: A Retrospective Medical Record Review of Utilization Patterns and Medical Resource Use Associated with Repository Corticotropin Injection among Patients with Rheumatologic Diseases in the United States

ObstaclePercentage (%) of patients
RA (n = 37)a PsA (n = 33)a DM/PM (n = 47)a SLE (n = 9)a,b
Prior authorization61715155
High out-of-pocket cost52614762
Inadequate insurance coverage30292863
Formulary39272521
Lack of insurance coverage20343411
  1. DM/PM dermatomyositis/polymyositis, PsA psoriatic arthritis, RA rheumatoid arthritis, RCI repository corticotropin injection, SLE systemic lupus erythematosus
  2. aThe subset of patients in the cohort whose medical records indicated an obstacle to drug access. Some patients had more than one diagnosis of interest and are counted in more than one cohort
  3. bCaution, small n